Lilly and Incyte Report Positive One-Year Results...
Category : Clinical Trial Update 28 October 2025Eli Lilly and Company and Incyte have reported new one-year data from the Phase 3 BRAVE-AA-PEDS stud...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Johnson & Johnson Presents 52-Week Phase 3 Data fo...
Category : Clinical Trial Update 28 October 2025Johnson & Johnson announced new long-term, 52-week data from the Phase 3 ICONIC-TOTAL study eval...
Sahyadri Hospital, Hadapsar, Becomes First in the...
Category : Certificates/Accreditation 28 October 2025Sahyadri Hospital, Hadapsar, has announced that it has become the first hospital in Hadapsar to rece...
Eli Lilly Reports Positive Data on Omvoh in Ulcera...
Category : Clinical Trial Update 28 October 2025New data from Eli Lilly and Company revealed that patients with moderately to severely active ulcera...
Medtronic Reports Three-Year Data Confirming Durab...
Category : Clinical Trial Update 27 October 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced final results from th...
Latest Newsletter Post
-
Eli Lilly Reports Positive Data on..
28 October 2025
-
Sahyadri Hospital, Hadapsar, Become..
28 October 2025
-
Johnson & Johnson Presents 52-Week..
28 October 2025
-
Lilly and Incyte Report Positive On..
28 October 2025
-
Secarna Pharmaceuticals and Scenic..
27 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com